NCT02738398View on ClinicalTrials.gov

FDG PET/CT in Lung Cancer Staging

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Non-Small Cell Lung Cancer (NSCLC)
Interventions
RADIATION

FDG PET/CT

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02738398 - FDG PET/CT in Lung Cancer Staging | Biotech Hunter | Biotech Hunter